NEW YORK, July 24, 2015 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP:

http://photos.prnewswire.com/prnvar/20120409/MM84375LOGO

To: All persons or entities who purchased or otherwise acquired securities of Puma Biotechnology Inc. ("Puma Biotechnology") (NYSE: PBYI) between July 23, 2014 and May 13, 2015.

You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Central District of California. If you purchased or otherwise acquired Puma Biotechnology shares between July 23, 2014 and May 13, 2015, your rights may be affected by this action. To get more information go to:

http://zlk.9nl.com/pumabiotechnology

or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that defendants made false and/or misleading statements and/or failed to disclose that: (a) the Company's New Drug Application filing would be for a positive early stage breast cancer indication, rather than the previously announced metastatic breast cancer; (b) Puma would need to submit additional safety data from preclinical carcinogenicity studies with its NDA filing, which Puma did not have; (c) the additional studies required would push the timelines for filing the NDA; and (d) the Company overstated results from its Phase III ExteNET Trial.

If you suffered a loss in Puma Biotechnology you have until August 3, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

Logo - http://photos.prnewswire.com/prnh/20120409/MM84375LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-levi--korsinsky-llp-notifies-shareholders-of-puma-biotechnology-inc-of-pendency-of-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-august-3-2015--pbyi-300118535.html

SOURCE Levi & Korsinsky, LLP